Skip to main content
SpringerLink
Log in

Three adiponectin rs1501299G/T, rs822395A/C, and rs822396A/G polymorphisms and risk of cancer development: a meta-analysis

  • Research Article
  • Published:
Tumor Biology

Abstract

Many epidemiological studies have studied the associations between adiponectin rs1501299G/T, rs822395A/C, and rs822396A/G polymorphisms and risk of cancer development, while conflicting results have been reported. Therefore, we conducted a meta-analysis to assess the associations. We retrieved the following databases: Medline, Embase, Web of Science, and Wanfang, and the latest update date was 15th of August 2012. Odds ratio (OR) and corresponding 95 % confidence interval (95 % CI) were calculated by using fixed- or random-effect model. Overall, there were 13 case-control studies consisting of 7,902 subjects for adiponectin rs1501299G/T, seven studies consisting of 6,209 subjects for rs822395A/C, and seven studies consisting of 5,791 subjects for rs822396A/G polymorphism in this study. Combined analyses indicated that neither adiponectin rs822395A/C nor rs822396A/G was associated with risk of cancer incidence (OR (95 % CI) 0.91 (0.77–1.77), P z test = 0.26 for CC vs. AA and 0.96 (0.87–1.05) for C carriers vs. A carriers, P z test = 0.33 for rs822395A/C; 0.88 (0.53–1.47) for GG vs. AA, P z test = 0.63 and 0.94 (0.84–1.04) for G carriers vs. A carriers, P z test = 0.24 for rs822396A/G polymorphism). Similarly, combined analysis also indicated that adiponectin rs1501299G/T polymorphism was not associated with risk of cancer development (OR (95 % CI) 0.86 (0.73–1.01) for TT vs. GG, P z test = 0.07 and 1.17 (0.98–1.39), P z test = 0.08). However, when stratified analyses were conducted, the result indicated that T allele was significantly associated with increased cancer risk for Caucasians (OR (95 % CI) 1.28 (1.06–1.64) and P z test = 0.01 for G carriers vs. T carriers) and associated with increased risk of colorectal cancer development while with decreased risk of prostate cancer incidence compared to G allele (OR (95 % CI) 1.34 (1.14–1.57), P z test < 0.01 for G carriers vs. T carriers for colorectal cancer; 0.80 (0.65–0.97), P z test = 0.03 for TG vs. GG for prostate cancer). In summary, this meta-analysis indicated that adiponectin rs1501299G/T, rather than rs822395A/C and rs822396A/G polymorphism, was associated with risk of cancer development, especially for colorectal and prostate cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277–300.

    Article  PubMed  Google Scholar 

  2. Moghaddam AA, Woodward M, Huxley R. Obesity and risk of colorectal cancer: a meta-analysis of 31 studies with 70,000 events. Cancer Epidemiol Biomarkers Prev. 2007;16:2533–47.

    Article  PubMed  Google Scholar 

  3. Yang P, Zhou Y, Chen B, et al. Overweight, obesity and gastric cancer risk: results from a meta-analysis of cohort studies. Eur J Cancer. 2009;45:2867–73.

    Article  PubMed  Google Scholar 

  4. Shehzad A, Khan S, Sup Lee Y. Curcumin molecular targets in obesity and obesity-related cancers. Future Oncol. 2012;8:179–90.

    Article  PubMed  CAS  Google Scholar 

  5. Yamamoto S, Nakagawa T, Matsushita Y, et al. Visceral fat area and markers of insulin resistance in relation to colorectal neoplasia. Diabetes Care. 2010;33:184–9.

    Article  PubMed  CAS  Google Scholar 

  6. Ho GY, Wang T, Gunter MJ, et al. Adipokines linking obesity with colorectal cancer risk in postmenopausal women. Cancer Res. 2012;72:3029–37.

    Article  PubMed  CAS  Google Scholar 

  7. Gialamas SP, Petridou ET, Tseleni-Balafouta S, et al. Serum adiponectin levels and tissue expression of adiponectin receptors are associated with risk, stage, and grade of colorectal cancer. Metabolism. 2011;60:1530–8.

    Article  PubMed  CAS  Google Scholar 

  8. Oh SW, Park CY, Lee ES, et al. Adipokines, insulin resistance, metabolic syndrome, and breast cancer recurrence: a cohort study. Breast Cancer Res. 2011;13:R34.

    Article  PubMed  Google Scholar 

  9. An W, Bai Y, Deng SX, et al. Adiponectin levels in patients with colorectal cancer and adenoma: a meta-analysis. Eur J Cancer Prev. 2012;21:126–33.

    Article  PubMed  CAS  Google Scholar 

  10. Tworoger SS, Eliassen AH, Kelesidis T, et al. Plasma adiponectin concentrations and risk of incident breast cancer. J Clin Endocrinol Metab. 2007;92:1510–6.

    Article  PubMed  CAS  Google Scholar 

  11. Spyridopoulos TN, Petridou ET, Dessypris N, et al. Inverse association of leptin levels with renal cell carcinoma: results from a case-control study. Hormones (Athens). 2009;8:39–46.

    Google Scholar 

  12. Goktas S, Yilmaz MI, Caglar K, et al. Prostate cancer and adiponectin. Urology. 2005;65:1168–72.

    Article  PubMed  Google Scholar 

  13. Kaklamani VG, Sadim M, Hsi A, et al. Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk. Cancer Res. 2008;68:3178–84.

    Article  PubMed  CAS  Google Scholar 

  14. Beebe-Dimmer JL, Zuhlke KA, Ray AM, Lange EM, Cooney KA. Genetic variation in adiponectin (ADIPOQ) and the type 1 receptor (ADIPOR1), obesity and prostate cancer in African Americans. Prostate Cancer Prostatic Dis. 2010;13:362–8.

    Article  PubMed  CAS  Google Scholar 

  15. He B, Pan Y, Zhang Y, et al. Effects of genetic variations in the adiponectin pathway genes on the risk of colorectal cancer in the Chinese population. BMC Med Genet. 2011;12:94.

    Article  PubMed  CAS  Google Scholar 

  16. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.

    PubMed  CAS  Google Scholar 

  17. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.

    Article  PubMed  CAS  Google Scholar 

  18. Cui E, Deng A, Wang X, et al. The role of adiponectin (ADIPOQ) gene polymorphisms in the susceptibility and prognosis of non-small cell lung cancer. Biochem Cell Biol. 2011;89:308–13.

    Article  PubMed  CAS  Google Scholar 

  19. Kaklamani V, Yi N, Zhang K, et al. Polymorphisms of ADIPOQ and ADIPOR1 and prostate cancer risk. Metabolism. 2011;60:1234–43.

    Article  PubMed  CAS  Google Scholar 

  20. Kaklamani VG, Wisinski KB, Sadim M, et al. Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk. JAMA. 2008;300:1523–31.

    Article  PubMed  CAS  Google Scholar 

  21. Tsilidis KK, Helzlsouer KJ, Smith MW, et al. Association of common polymorphisms in IL10, and in other genes related to inflammatory response and obesity with colorectal cancer. Cancer Causes Control. 2009;20:1739–51.

    Article  PubMed  Google Scholar 

  22. Wang MH, Helzlsouer KJ, Smith MW, et al. Association of IL10 and other immune response- and obesity-related genes with prostate cancer in CLUE II. Prostate. 2009;69:874–85.

    Article  PubMed  CAS  Google Scholar 

  23. Partida-Perez M, de la Luz Ayala-Madrigal M, Peregrina-Sandoval J, et al. Association of LEP and ADIPOQ common variants with colorectal cancer in Mexican patients. Cancer Biomark. 2010;7:117–21.

    PubMed  CAS  Google Scholar 

  24. Al Khaldi RM, Al Mulla F, Al Awadhi S, Kapila K, Mojiminiyi OA. Associations of single nucleotide polymorphisms in the adiponectin gene with adiponectin levels and cardio-metabolic risk factors in patients with cancer. Dis Markers. 2011;30:197–212.

    PubMed  CAS  Google Scholar 

  25. Al-Harithy RN, Al-Zahrani MH. The adiponectin gene, ADIPOQ, and genetic susceptibility to colon cancer. Oncol Lett. 2012;3:176–80.

    PubMed  CAS  Google Scholar 

  26. Keku TO, Vidal A, Oliver S, et al. Genetic variants in IGF-I, IGF-II, IGFBP-3, and adiponectin genes and colon cancer risk in African Americans and Whites. Cancer Causes Control. 2012;23:1127–38.

    Article  PubMed  Google Scholar 

  27. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348:1625–38.

    Article  PubMed  Google Scholar 

  28. Shin MJ, Jang Y, Koh SJ, et al. The association of SNP276G>T at adiponectin gene with circulating adiponectin and insulin resistance in response to mild weight loss. Int J Obes (Lond). 2006;30:1702–8.

    Article  CAS  Google Scholar 

  29. Doyle SL, Donohoe CL, Lysaght J, Reynolds JV. Visceral obesity, metabolic syndrome, insulin resistance and cancer. Proc Nutr Soc. 2012;71:181–9.

    Article  PubMed  CAS  Google Scholar 

  30. Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001;7:941–6.

    Article  PubMed  CAS  Google Scholar 

  31. Kubota N, Terauchi Y, Yamauchi T, et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem. 2002;277:25863–6.

    Article  PubMed  CAS  Google Scholar 

  32. Rose DP, Komninou D, Stephenson GD. Obesity, adipocytokines, and insulin resistance in breast cancer. Obes Rev. 2004;5:153–65.

    Article  PubMed  CAS  Google Scholar 

  33. Saxena A, Chumanevich A, Fletcher E, et al. Adiponectin deficiency: role in chronic inflammation induced colon cancer. Biochim Biophys Acta. 2012;1822:527–36.

    Article  PubMed  CAS  Google Scholar 

  34. Maeda N, Takahashi M, Funahashi T, et al. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes. 2001;50:2094–9.

    Article  PubMed  CAS  Google Scholar 

  35. Grisouard J, Dembinski K, Mayer D, et al. Targeting AMP-activated protein kinase in adipocytes to modulate obesity-related adipokine production associated with insulin resistance and breast cancer cell proliferation. Diabetol Metab Syndr. 2011;3:16.

    Article  PubMed  CAS  Google Scholar 

  36. Chen B, Zhou Y, Yang P, et al. CDH1–160C>A gene polymorphism is an ethnicity-dependent risk factor for gastric cancer. Cytokine. 2011;55:266–73.

    Article  PubMed  CAS  Google Scholar 

  37. Qi L, Doria A, Manson JE, et al. Adiponectin genetic variability, plasma adiponectin, and cardiovascular risk in patients with type 2 diabetes. Diabetes. 2006;55:1512–6.

    Article  PubMed  CAS  Google Scholar 

  38. Ong KL, Li M, Tso AW, et al. Association of genetic variants in the adiponectin gene with adiponectin level and hypertension in Hong Kong Chinese. Eur J Endocrinol. 2010;163:251–7.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work is financially supported by the Natural Science Foundation of China (grant no. 81150010).

Conflicts of interest

None

Author information

Authors and Affiliations

  1. Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China

    Hui-Jie Fan, Jing-Jing Wu, Yong-Xu Jia, Ming Gao, Ming-Jun Li & Yan-Ru Qin

  2. Department of Gynaecology and Obstetrics, The First Affiliated Hospital of Xinxiang Medical College, Xinxiang, 453000, China

    Zheng-Fang Wen

  3. Laboratory Center, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, 450008, China

    Ben-Ling Xu

Authors
  1. Hui-Jie Fan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Zheng-Fang Wen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ben-Ling Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jing-Jing Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yong-Xu Jia
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ming Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ming-Jun Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yan-Ru Qin
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yan-Ru Qin.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fan, HJ., Wen, ZF., Xu, BL. et al. Three adiponectin rs1501299G/T, rs822395A/C, and rs822396A/G polymorphisms and risk of cancer development: a meta-analysis. Tumor Biol. 34, 769–778 (2013). https://doi.org/10.1007/s13277-012-0606-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-012-0606-x

Keywords

Search

Navigation